The Clostridioides difficile Infections (Clostridium difficile Associated Disease) drugs in development market research report provides comprehensive information on the therapeutics under development ...

Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

Clostridium difficile infection (CDI ... Although metronidazole and vancomycin are and have been the mainstay treatment options for CDI, there are some unmet medical and therapeutical needs.

Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

The product is based on purified Firmicutes bacterial spores delivered in an oral capsule that is designed to encourage the regrowth of healthy bacteria after antibiotic treatment for C.

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Clostridium difficile colitis (CDC) is an infection of the intestine caused by the bacteria Clostridioides difficile. Symptoms may be mild, but life-threatening complications can develop. Those at ...

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

It also often resists antibiotic treatment, leaving it free to infect the colon and cause diarrhea, nausea, fever and, in severe cases, sepsis and death. Boulder, Colorado-based biotech Crestone ...